UNION, N.J.--(BUSINESS WIRE)--July 15, 2005-- Designed and Developed Specifically for the Life Sciences and Healthcare Industries Data Reduction Systems Corp. (DRS) (www.drscorp.com), a leading provider of information products and services, announced today that its patent application on its PharmaSync(TM) Electronic Real-Time Data Collection Tool has been allowed by the United States Patent and Trademark Office. PharmaSync(TM) was invented for pharmaceutical companies as an alternative to conventional paper based methods, which typically track prescription drug samples slated for distribution at some future date. Conversely, PharmaSync(TM) carries out all tracking and distribution activities in real time - from samples request through to samples disbursement from a central inventory. The soon-to-be patented technology enables pharmaceutical companies to eliminate paper documents, speed dissemination of data, and improve data integrity. Collectively, these and other features are aimed at making it easier for organizations to manage and comply with a wide range of compliance requirements driven by regulations mandated by the Prescription Drug Marketing Act (PDMA).
